Investigations related to the development of a leprosy vaccine.
D000907:Antibodies, Bacterial / Q000032:analysis; D001500:BCG Vaccine / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000009:adverse effects / Q000627:therapeutic use*; D004198:Disease Susceptibility; D006099:Granuloma / Q000473:pathology; D006801:Humans; D006968:Hypersensitivity, Delayed; D007918:Leprosy / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D008264:Macrophages / Q000276:immunology / Q000473:pathology; D009166:Mycobacterium leprae / Q000276:immunology*; D013601:T-Lymphocytes / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology; D014611:Vaccination; D014687:Venezuela
D000907:Antibodies, Bacterial; D001500:BCG Vaccine; D001428:Bacterial Vaccines